Misfolding of CasBrE SU is reversed by interactions with 4070A Env: implications for gammaretroviral neuropathogenesis
© Li and Lynch; licensee BioMed Central Ltd. 2010
Received: 29 July 2010
Accepted: 5 November 2010
Published: 5 November 2010
CasBrE is a neurovirulent murine leukemia virus (MLV) capable of inducing paralytic disease with associated spongiform neurodegeneration. The neurovirulence of this virus has been genetically mapped to the surface expressed subunit (SU) of the env gene. However, CasBrE SU synthesized in the absence of the transmembrane subunit (TM) does not retain ecotropic receptor binding activity, indicating that folding of the receptor binding domain (RBD) requires this domain. Using a neural stem cell (NSC) based viral trans complementation approach to examine whether misfolded CasBrE SU retained neurovirulence, we observed CasBrE SU interaction with the "non-neurovirulent" amphotropic helper virus, 4070A which restored functional activity of CasBrE SU.
Herein, we show that infection of NSCs expressing CasBrE SU with 4070A (CasES+4070A-NSCs) resulted in the redistribution of CasBrE SU from a strictly secreted product to include retention on the plasma membrane. Cell surface cross-linking analysis suggested that CasBrE SU membrane localization was due to interactions with 4070A Env. Viral particles produced from CasES+4070A-NSCS contained both CasBrE and 4070A gp70 Env proteins. These particles displayed ecotropic receptor-mediated infection, but were still 100-fold less efficient than CasE+4070A-NSC virus. Infectious center analysis showed CasBrE SU ecotropic transduction efficiencies approaching those of NSCs expressing full length CasBrE Env (CasE; SU+TM). In addition, CasBrE SU-4070A Env interactions resulted in robust ecotropic superinfection interference indicating near native intracellular SU interaction with its receptor, mCAT-1.
In this report we provided evidence that 4070A Env and CasBrE SU physically interact within NSCs leading to CasBrE SU retention on the plasma membrane, incorporation into viral particles, restoration of mCAT-1 binding, and capacity for initiation of TM-mediated fusion events. Thus, heterotropic Env-SU interactions facilitates CasBrE SU folding events that restore Env activity. These findings are consistent with the idea that one protein conformation acts as a folding scaffold or nucleus for a second protein of similar primary structure, a process reminiscent of prion formation. The implication is that template-based protein folding may represent an inherent feature of neuropathogenic proteins that extends to retroviral Envs.
Certain MLVs are capable of causing severe progressive non-inflammatory spongiform motor neuron disease when inoculated into susceptible neonatal mice. The prototypic virus of this class, referred to as CasBrE, was first isolated from wild mice and shown to cause a paralytic wasting disease with low incidence and a long incubation period, highly reminiscent of certain prion diseases and amyotrophic lateral sclerosis (ALS) [1–3]. Genetic mapping studies have indicated that the primary viral neurovirulence determinants reside within the viral env gene, specifically to within the region encoding the SU subunit (cf., [4–10]). As a result, it has been speculated that CNS expression of neurovirulent MLV Env protein alone might be sufficient for inducing neurodegeneration . Attempts to address this issue through the generation of transgenic or NSC-based chimeric mice expressing neurovirulent MLV Envs have yet to provide a clear resolution to this question [11–14].
We have previously demonstrated that over expression of the CasBrE Env protein, either SU or SU/TM, from engrafted NSCs does not induce acute spongiform pathology. Moreover, we have shown that dissemination of the CasBrE env gene from transplanted packaging/producer NSCs also does not cause spongiosis, despite Env expression within host microglia, a major CNS MLV target. Therefore, we were interested in examining whether additional retroviral proteins might also need to be delivered to host cells to induce neuropathogenic changes. To address this question, we have been exploring an NSC-based strategy wherein a "non-neurovirulent" amphotropic virus, 4070A, is used to pseudotype and trans complement the packagable CasBrE env vector, CasE, which encodes both the SU and TM subunits. The expectation being that if CasBrE env alone is not sufficient for disease, supplying Gag-pol elements in trans will provide the missing components. To address whether Env needed to be membrane associated, as has been reported for prions , we also investigated the effects of pseudotyping CasES, a vector that encodes CasBrE SU without the Env TM subunit. However, it is important to note that CasES expression from NSCs results in SU protein that is not able to efficiently bind to its cognate receptor, mCAT-1, a murine cationic amino acid transporter , when assessed by superinfection interference . Why the CasBrE SU in the absence of the TM subunit had lost receptor binding activity despite the preservation of the RBD sequences in the N-terminal half of SU was not clear. Nonetheless, the loss of receptor binding might allow us to also investigate whether this activity could also be important for neuropathogenesis. However, before we could address these questions in vivo, we needed to examine whether 4070A Env and the CasBrE SU interacted within the engineered NSCs, as previous reports have demonstrated that the Env RBD domain could bind and trans complement Env proteins whose RBDs had been deleted or replaced with an alternative receptor specificity . This possibility becomes increasingly important when considering how viral elements engineered into transplanted NSCs and delivered to the CNS could interact to facilitate acute spongiform neuropathogenesis. In this report, we show that CasBrE SU and 4070A proteins physically interact upon synthesis. This interaction results in CasBrE SU expression on the cell surface and facilitates its incorporation into viral particles. In addition, the interaction results in the restoration of CasBrE SU-mCAT-1 binding activity capable of establishing superinfection interference and facilitating ecotropic receptor-dependent virus infection. The finding that SU folding can be affected by protein-protein interactions has significant implications for understanding how NSC-mediated viral pseudotyping and trans complementation in the brain act to precipitate spongiform neurodegeneration.
CasBrE SU is expressed on the cell surface upon NSC infection with an amphotropic helper virus
For vector pseudotyping controls, C17.2 NSCs were transduced with vectors encoding GFP. However, due to a lack of stable GFP expression, they could not be directly compared with CasBrE Env encoding vectors and their utility in vivo would be similarly limited. In this regard, GFP-sorted NSCs transduced with hrGFP (from Victoria; Stratagene) showed that within 10 days after isolation less than 50% of this population exhibited persistent GFP expression (Figure 2, hrGFP, -4070A). The loss of GFP expressing cells reoccurred even after repeated (3×) FACS selection. Surprisingly, infection of these cells with 4070A resulted in a higher level of cells persistently expressing GFP (+4070A), which was maintained through multiple cell passages without reselection. In parallel experiments with NSCs transduced with Aequorea EGFP, we were unable to generate NSCs that stably expressed GFP, regardless of whether they were infected with 4070A.
4070A infection of CasBrE Env expressing NSCs influences Env and Gag expression levels
To assess whether both CasBrE and 4070A Env proteins were incorporated into viral particles, culture supernatants from the control, CasES- and CasE-NSCs with and without 4070A, were subjected to centrifugation to pellet virus. The sedimented fractions were assessed for CasBrE and 4070A Env by immunoblot. Figure 3C, far right panels show that both 4070A and CasBrE gp70 s were associated with p30Gag in the pellets indicating that both 4070A and CasBrE Envs were being incorporated into virions. This is especially noteworthy for the CasES+4070A-NSCs as CasBrE SU has no inherent membrane interacting domain and thus was likely interacting with 4070A proteins to achieve virion incorporation. The small amount of CasBrE SU noted after sedimentation of the CasES supernatant without 4070A represents trace amounts of medium containing high levels of SU rather than the sedimentation of SU aggregates.
CasBrE SU physically interacts with 4070A on the plasma membrane of NSCs
To further examine what proteins were contained in the low mobility (high molecular weight), DTSSP-crosslinked bands from CasES+4070A- and CasE+4070A-NSCs, extracts were subjected to non-reducing SDS-PAGE in the first dimension followed by reducing SDS-PAGE in the second dimension, with subsequent analysis by Western blotting for CasBrE Env and 4070A viral proteins. Two CasBrE immunoreactive bands corresponding to pr85 and 60 kD proteins, and one amphotropic pr85 Env band (Figure 4B, arrows) were readily detected in the low mobility cross-linked bands obtained from CasES+4070A cells; again, suggesting that CasBrE SU and 4070A Env proteins may directly interact. Similar results were observed for CasE+4070A NSCs with both pr85 and gp70 bands being found in the low mobility bands (Figure 4C), however, because CasE-NSCs and 4070A-NSCs alone also show low mobility complexes after DTSSP treatment, it was not possible to distinguish between homo- versus hetero-oligomers upon dissociation in the presence of reducing agent.
4070A helper virus-infected NSCs efficiently transduce viral and vector genomes
CasBrE SU-4070A Env interactions facilitate virus entry via the ecotropic receptor
CasBrE Env-NSC mediated superinfection of amphotropic-restricted targets through cell-cell contact
Infectious Center Efficiencyc
10.5 ± 1.3
2.5 ± 1
67 ± 8.3
18 ± 3
16.5 ± 3
49 ± 5.0
64.7 ± 7.2
16.2 ± 3.8
Helper virus-infected NSCs deliver both virus and vector to naive target cells
To assess whether the 4070A-infected vector-expressing NSCs could deliver both virus and vector to individual dunni fibroblasts to facilitate trans complementation within those targets, infectious center foci were assessed for CasBrE Env and 4070 Gag (Figure 7). Examination of the merged images showed that virtually all the Env+ cells (green) were also Gag+ (red) with CasE+4070A-NSCs. In foci generated from CasES+4070A NSCs approximately 60% of cells were double positive, whereas, approximately 15% were singly positive for CasBrE SU, and 25% singly positive for Gag. Analysis of hrGFP+4070A NSCs gave results similar to those generated by the CasES vector with between 50-70% of cells in foci expressing GFP and Gag (not shown).
4070A helper virus infection of CasBrE Env expressing NSCs does not result in the generation of recombinant replication competent CasBrE virus
CasBrE SU-4070A Env interactions facilitate efficient binding and blocking of mCAT-1 in NSCs
In this report we examined the capacity of the 4070A amphotropic virus to trans complement and pseudotype CasBrE env vectors when co-expressed in NSCs as a prelude to transplanting these cells in the CNS in order to define what retroviral elements and interactions were required to induce spongiform neurodegeneration. This analysis revealed that the engineered NSCs could indeed deliver both the env vector and complementing 4070A virus to target cells in culture, in the absence of detectable recombinant virus. Given these results, the potential exists for exploiting this capacity for NSC-mediated pseudotyping and trans complementation to reveal insights into the elements and activities involved in retroviral neurovirulence and their capacity to target certain CNS cell types. However, our in vitro analysis herein, also revealed how viral protein-protein interactions might be expected to alter the interpretation of the in vivo experiments where these tools are employed. Specifically, we showed that direct heteromeric interactions between 4070A Env and the protein product of the CasES vector, CasBrE SU, restored CasBrE SU's capacity to associate with the plasma membrane, become incorporated into viral particles, bind to the ecotropic receptor and trigger virus fusion.
We previously reported that when CasBrE SU is made in the absence of TM subunit sequences, the protein possessed little ecotropic receptor binding activity and was secreted from the cell . Presumably the absence of TM sequences in the Env precursor protein prevented the normal folding of the CasBrE receptor binding domain (RBD) found within SU. The loss of receptor binding activity for CasBrE SU was not predicted given the findings of Davey et al. showing that eukaryotic cell synthesis of the N-terminal one third of the Friend virus SU results in receptor binding activity equivalent to the full length protein (SU/TM) . Spatial modeling of the CasBrE RBD sequence, based on the crystal structure defined for the RBD from the Friend virus , predicts a similar structure for CasBrE RBD (unpublished observations). Thus, sequences in the latter two thirds of SU may negatively influence the proper folding of the CasBrE SU in the absence of TM sequences. It is clear from studies by Lavillette et al., that there are critical interactions between the C-terminal domain of SU and the RBD that affect various Env entry activities . Thus, the results here suggest that, at least for CasBrE Env, sequences within TM may help to facilitate the proper folding of these domains in CasBrE SU.
Given the virtual absence of CasBrE SU receptor binding activity and cell surface expression originally observed in CasES NSCs, we predicted that 4070A infection of CasBrE SU-expressing NSCs would result in the production of virus that would demonstrate only amphotropic tropism while packaging either 4070A or CasES genomes. It was therefore surprising to observe CasBrE SU on the cell surface of CasES+4070A-NSCs in the absence of any recombinant virus. The follow-up cross-linking, sedimentation, infection and superinfection analyses demonstrated that direct 4070A Env-CasBrE SU interactions increased ecotropic receptor interactions by 10,000 fold and facilitated SU incorporation into virions that could activate fusion activity.
How the lost SU activities were restored is not clear, but it is of interest to speculate that the 4070A Env may have acted as a folding template for CasBrE SU during its synthesis through the secretory pathway. In this way, Env would be analogous to the prion protein where the scrapie form is able to direct the folding and ultimate conformation of the unfolded protein through direct interactions. This idea appears to be a reoccurring theme in a diverse array of infectious, sporadic and genetic neurodegenerative diseases often characterized by protein aggregation. While retroviral neuropathogenesis is not characterized by identifiable protein aggregates, their ability to form multimers may provide a structural link between such diseases. The possibility that template-based protein folding extends to retrovirus-induced neurodegeneration such as HTLV-1 associated myelopathy or HIV associated dementia is provocative.
An alternative to the template-based folding idea is that SU interactions with 4070A SU or TM may have facilitated more efficient or prolonged SU interactions with ER chaperones through non-covalent tethering of SU to the membranes in the secretory pathway. However, we observed that CasBrE SU synthesized alone appears to be fully glycosylated and of the correct molecular size upon its secretion into the medium, suggesting that it has been routed and processed through the requisite ER-golgi protein quality control machinery that includes lectins and sugar processing enzymes (reviewed in [23–25]). Whether the addition of a simple transmembrane domain or a glycophosphatidyl inositol linker to CasBrE SU would result in a similar restoration of CasBrE SU binding to mCAT-1 might help distinguish between these two possibilities.
The observation that correctly folded CasBrE SU could facilitate ecotropic receptor binding and entry in the presence of amphotropic Env is consistent with the modular nature of type-C retroviral Envs described by Barnett et al. . These investigators showed that the addition of soluble Friend RBD could restore infectivity when the RBD was deleted from ecotropic, amphotropic, or xenotropic Envs. Morever, this group showed that RBD could enhance infectivity 50-fold when Env RBD sequences were replaced by erythropoietin as an alternate receptor specificity. Herein, CasBrE-SU facilitated ecotropic receptor-mediated virus fusion indicating that the CasBrE SU induced conformational changes in 4070A derived-TM trimers required for membrane fusion. Whether this involved CasBrE SU binding to functional 4070A SU/TM monomers, dimers, or trimers, or represented CasBrE SU displacement of 4070A SU to interact with TM is not clear. The cross-linking studies appear to suggest that heteromeric CasBrE-4070A SU-SU interactions were occurring, but the exact nature of the fusigenic structures is a matter of conjecture at this stage. Interestingly, a previous report by Yang et al. suggests that ecotropic and amphotropic Env hetero-trimers are not formed when co-expressed in the same cell, however, this apparent discrepancy could be accounted for by the fact that differing ecotropic viruses were employed in the two studies. In this regard, the CasBrE virus was initially co-isolated from the wild along with amphotropic viruses , suggesting that the two viruses likely co-evolved. Nonetheless, since we did not observe full restoration of CasBrE Env binding and fusion activity in this complementation paradigm, it suggests that CasBrE SU-4070A TM heterodimer formation was either not highly efficient or that misfolded CasBrE SU might also compete with natively folded SU for association with 4070A SU/TM or TM proteins. It is clear that a more detailed analysis of the protein complexes being formed will be required to reveal insight into the nature of the specific protein-protein interactions taking place.
Given that previous experiments investigating prion protein neuropathogenesis have demonstrated that the glycophosphatidyl inositol membrane anchor was required for prion protein induced neurodegeneration but not replication , we initially thought that NSC-mediated 4070A delivery of CasES to CNS cells would allow us to assess whether ecotropic receptor binding activity and/or Env membrane association were required for MLV-induced spongiform neurodegeneration. However, since these Env activities were restored by CasBrE SU-4070A Env interactions, these questions cannot be effectively addressed using this helper virus pseudotyping approach. Nonetheless, the capacity for trans complementation in vivo examined in the companion study was able to show that ecotropic entry is a critical step in the pathogenic process, and that the "non-neurovirulent" virus amphotropic virus contains neurovirulent elements that could be revealed by such an analysis. Perhaps more dramatically, these findings of Env-SU interactions highlight the difficulty in assessing which in vivo Env interactions are responsible for the induction of neuropathogenic changes given that the mouse genome, like that of other mammals, is replete with retroviral sequences. Ruling out that exogenous viral proteins interact with host retroviral elements to cause disease may be a Sisyphean task.
The findings presented here show that co-expression of 4070A and CasBrE SU results in a physical interaction between 4070A Env and CasBrE SU. This interaction facilitates CasBrE SU retention on the plasma membrane, incorporation into viral particles and restoration of its ability to interact with its receptor, mCAT-1. Moreover, Env-SU oligomers were capable of initiating ecotropic receptor-dependent TM-mediated fusion events, despite reduced efficiencies in free virus. Thus, the results indicate that heterotropic Env-SU interactions that occur during protein synthesis facilitate CasBrE SU folding events and interactions with TM such that ecotropic viral binding and membrane fusion events were almost fully restored. This template based folding process is reminiscent of prion formation, where one protein conformation acts as a scaffold for the folding of a second protein of similar primary structure. These findings support the idea that protein scaffold-based protein folding represents an inherent feature of neuropathogenic proteins that appears to extend to retroviral Envs.
The CasBrE env expression vectors CasE (SU/TM), CasES (SU), described previously , contain the env gene derived from the CasBrE molecular clone 15.1 [27, 28] (GenBank accession number X57540) inserted into the pSFF vector . In order to assess effects associated with vector alone, a pSFF-based vector encoding humanized GFP from Renilla (hrGFP, Stratagene) was generated by introducing a Xho I and Sal I fragment from pFB-hrGFP (Promega) into the multiple cloning site of pSFF.
C17.2 neural stem cell lines with and without expression of CasBrE SU or SU/TM have been described previously [11, 30] and were grown on Primaria dishes (Falcon) in DMEM supplemented with 10% fetal bovine serum and 100 U of penicillin and streptomycin per ml. Mus dunni, NIH 3T3 fibroblasts, and PT67 packaging/producer cells (Invitrogen) were maintained in DMEM with 10% new born calf serum and 100 U of penicillin and streptomycin per ml on Nunclon D™ dishes (Nunc).
HrGFP-NSCs were generated by exposing C17.2 cells to hrGFP virus at a multiplicity of infection of 1 in the presence of 8 μg/mL polybrene. Positive NSCs were sorted by flow cytometry with the brightest 10% selected and used for subsequent analysis. C17.2 NSCs with and without SU, SU/TM, hrGFP or 15-1EIH were infected with the 4070A virus at an MOI of 1 in the presence of 8 μg/mL polybrene, and passaged 4 times prior to analysis for CasBrE Env and hrGFP expression and 4070A virus pseudotyping.
4070A amphotropic virus stocks were generated by transfecting the permuted proviral clone p4070A  into NIH3T3 cells. Virus encoding hrGFP was generated by co-transfection of PT67 packaging producer cells (Invitrogen) with pCDNA3.1-hygro and phrGFP followed by collection of viral supernatants from hygromycin selected cultures. Similarly, CasE, CasES, and SFF-FE virus stocks were generated by transfection of PT67 cells with the corresponding plasmid.
NSCs were removed from tissue culture plates by using 0.05% trypsin with EDTA (Gibco), quenched with DMEM+10% NCS, washed with PBS, and incubated at 4°C for 30 minutes with the mouse monoclonal antibody 697 for detecting CasBrE Env , or mouse monoclonal 48 for Friend 57 Env. Cells were washed three times with PBS, and incubated with Alexa Fluor 488-conjugated goat anti-mouse IgG (Molecular Probes) for another 30 min before analysis. HrGFP expression within NSCs was analyzed directly. Analysis and sorting was carried out on an Altra Flow Cytometer (Beckman/Coulter).
Tissue culture cell extracts were generated as previously outlined [11, 33] and equivalent samples were separated by 8-10% SDS-PAGE, transferred to nitrocellulose membrane, blocked with 5% nonfat milk in TBS. To detect CasBrE Env and SU mouse monoclonal antibody 697 was used. Gag proteins were detected using rat anti-capsid R187 monoclonal antibody or rabbit anti-capsid antisera R3. Amphotropic viral proteins were detected using swine anti-AMLV serum (NCI). Primary antibodies or antisera was detected using horseradish peroxidase (HRP)-labeled goat anti-mouse IgG (Southern Biotechnologies), HRP-rabbit anti-swine IgG (RDI), HRP-donkey anti-rat IgG (Jackson Immunoresearch), or HRP-goat anti-rabbit IgG (Southern Biotechnologies), which were detected by chemiluminescence using ECL reagents (Pierce). Equivalent amounts of proteins were loaded for each tissue or cell sample and which was confirmed by Coomassie blue staining of a gel run in parallel in each experiment and by post transfer staining of the gel utilized in the transfer.
Chemical cross-linking of cell surface proteins
The water soluble chemical cross-linker dithiobis sulfosuccinimidylpropionate, DTSSP (Pierce), was dissolved in PBS (pH 7.2) to a concentration of 1 mM just before use. Full confluent cells were washed with PBS three times and then incubated with 1 mM DTSSP solution at room temperature for 30 min, followed by washing three times with Tris-buffered saline (pH 7.5). DTSSP treated cells were extracted by using lysis buffer containing 0.1% Triton X-100 as previously described . Cleared crosslinked samples were analyzed for viral proteins by Western blotting after non-reducing sodium dodecylsulfate polyacrylamide gel electrophoresis (SDS-PAGE) in the first dimension and reducing SDS-PAGE in the second dimension. Briefly, equivalent samples were boiled in SDS-PAGE sample buffer without DTT and resolved on an 8% gel and analyzed by Western blotting using monoclonal 697 for CasBrE Env and swine anti-AMLV (NCI) for 4070A proteins. To assess the composition of the cross-linked viral proteins, first dimension gel strips were equilibrated with sample buffer containing 100 mM DTT at room temperature for 15 min, positioned on the top of a second 8% gel, and then subjected to electrophoresis in the orthogonal directions and again analyzed for viral proteins by sequential immunoblotting.
Virus titration assay
Virus titers of tissue culture supernatants were determined by a focus forming assay on dunni cells . Supernatants collected from confluent cell cultures were frozen at -80°C before analysis. Viral Env positive foci were detected by using CasBrE Env specific MAb 697 or rat MAb 83A25  which recognizes an epitope common to all known endogenous and most exogenous MLV Envs. Alkaline phosphatase-labeled anti-mouse IgG or anti-rat IgG antibodies (Promega) and Western Blue stabilized substrate for alkaline phosphatase (Promega) were used. GFP positive foci were determined directly under a fluorescence microscope. Virus foci were scored based on their morphology as contiguous or non-contiguous, the latter being consistent with defective virus . To determine CasBrE SU positive or Gag positive foci, cells were permeabilized with ice cold methanol for 5 min before staining.
Infectious center assay
In order to assess NSCs' ability to disseminate viral vectors by cell-to-cell contact, infectious center assays were performed as outlined by Czub et al.  with minor modifications. Briefly, transduced C17.2 NSCs were treated with mitomycin C (Fisher) at 10 μg/ml in DMEM medium at 37°C for 2 hr, washed with PBS three times, trypsinized and resuspended in DMEM+10% FBS. Treated NSCs were seeded into TC-6 tissue culture plates using serial dilutions yielding from 100 to 2000 cells per well. Wells were also seeded with 1 × 105 dunni target cells per well. Once the dunni cells reach confluent, 697, R187 and MAbs 720/500/48 were used to detect CasBrE Env, amphotropic Gag and Friend Env expression respectively, followed by Alexa Fluor 488 goat anti-mouse IgG, Alex Fluor donkey 488 anti-goat IgG and Alexa Fluor 594 donkey anti-rat IgG (Molecular Probes) respectively, and foci were examined under the epifluorescence microscopy. Images were merged to colocalize CasBrE Env or SU and 4070A Gag expression in some instances. Plates without dunni cells were used to assess the plating efficiency of the mitomycin-treated NSCs and to normalize the number of foci generated.
To study whether CasES+4070A-NSCs were capable of delivering virus via the ecotropic receptor by cell-cell contact, a similar assay was performed in which naïve dunni and amphotropic 4070A virus infected dunni (DunniAm) cells were used as target cells. CasBrE SU positive foci were determined. As controls, CasE-4070A-NSCs and hrGFP-4070A-NSCs were analyzed in parallel.
Superinfection interference assays
To study whether CasBrE SU and Env could facilitate virus entry via the ecotropic receptor in the presence of the amphotropic 4070A virus, the superinfection interference assay was carried out as described previously . Briefly, NSCs were infected with serially diluted ecotropic MLV Fr57E in the presence of polybrene (8 μg/ml). Friend Env positive foci were evaluated by its' specific monoclonal antibodies 500, 48 and720 [38, 39], followed by Alexa Fluor 488 goat anti-mouse IgG (Molecular Probes). GFP positive foci were counted under a fluorescent microscopy directly.
To investigate whether the viruses generated by CasES+4070A-NSCs was capable of infecting targets via the ecotropic receptor, a similar method was carried out, in which 4070A virus infected-NIH 3T3 (3T3Am) cells and naïve 3T3 cells were used as target cells and SU positive foci were determined by MAb 697. As controls, viruses generated by CasE+4070A- and hrGFP+4070A-NSC culture were evaluated in parallel.
We thank Ninuan Huang and Rochelle Cutrone for technical support and Dr. Angelo DeLucia and Ms. Sandra Cardona for a critical reading of the manuscript. This work was supported in part by grants from the ALS Association and NIH grant NS37614 to WPL.
- Gardner MB: Retroviral spongiform polioencephalomyelopathy. Rev Infect Dis. 1985, 7: 99-110.View ArticlePubMedGoogle Scholar
- Gardner MB, Henderson BE, Officer JE, Rongey RW, Parker JC, Oliver C, Estes JD, Huebner RJ: A spontaneous lower motor neuron disease apparently caused by indigenous type-C RNA virus in wild mice. JNCI. 1973, 51: 1243-1254.PubMedGoogle Scholar
- Gardner MB, Rasheed S, Klement V, Rongey RW, Brown JC, Dworsky R, Henderson BE: Lower motor neuron disease in wild mice caused by indigenous type C virus and search for a similar etiology in human amyotrophic lateral sclerosis. UCLA Forum Med Sci. 1976, 19: 217-234.PubMedGoogle Scholar
- DesGroseillers L, Barrette M, Jolicoeur P: Physical Mapping of the paralysis-inducing determinant of a wild mouse ecotropic neurotropic virus. J Virol. 1984, 52: 356-363.PubMed CentralPubMedGoogle Scholar
- Jolicoeur P, Gravel C, Kay DG: Pathogenesis of murine spongiform myeloencephalopathy induced by a murine retrovirus. Molecular Neurovirology. Edited by: Roos RP. 1992, Totowa, NJ: Humana Press Inc, 199-224.View ArticleGoogle Scholar
- Portis JL: Genetic determinants of neurovirulence of murine oncornaviruses. Adv Virus Res. 2001, 56: 3-38. 10.1016/S0065-3527(01)56003-0.View ArticlePubMedGoogle Scholar
- Portis JL, Lynch WP: Dissecting the determinants of neuropathogenesis of the murine oncornaviruses. Virology. 1998, 247: 127-136. 10.1006/viro.1998.9240.View ArticlePubMedGoogle Scholar
- Wong PKY, Yuen PH: Molecular basis of neurologic disorders induced by a mutant ts1, of Moloney murine leukemia virus. Molecular Neurovirology: Pathogenesis of Viral CNS Infections. Edited by: Roos R. 1992, Totowa: Humana Press, 161-197.View ArticleGoogle Scholar
- Murphy SL, Honczarenko MJ, Dugger NV, Hoffman PM, Gaulton GN: Disparate regions of envelope protein regulate syncytium formation versus spongiform encephalopathy in neurological disease induced by murine leukemia virus TR. J Virol. 2004, 78: 8392-8399. 10.1128/JVI.78.15.8392-8399.2004.PubMed CentralView ArticlePubMedGoogle Scholar
- Paquette Y, Hanna Z, Savard P, Brousseau R, Robitaille Y, Jolicoeur P: Retrovirus-induced murine motor neuron disease: Mapping the determinant of spongiform degeneration within the envelope gene. Proc Natl Acad Sci USA. 1989, 86: 3896-3900. 10.1073/pnas.86.10.3896.PubMed CentralView ArticlePubMedGoogle Scholar
- Lynch WP, Snyder EY, Qualtiere L, Portis JL, Sharpe AH: Late virus replication events in microglia are required for neurovirulent retrovirus-induced spongiform neurodegeneration: evidence from neural progenitor-derived chimeric mouse brains. J Virol. 1996, 70: 8896-8907.PubMed CentralPubMedGoogle Scholar
- Kay DG, Gravel C, Pothier F, Laperriere A, Robitalle Y, Jolicoeur P: Neurological disease induced in transgenic mice expressing the env gene of the Cas-Br-E murine retrovirus. Proc Natl Acad Sci USA. 1993, 90: 4538-4542. 10.1073/pnas.90.10.4538.PubMed CentralView ArticlePubMedGoogle Scholar
- Yu YE, Choe W, Zhang W, Stoica G, Wong PK: Development of pathological lesions in the central nervoous system of transgenic mice expressing the env gene of ts1 Moloney murine leukemia virus in the absence of viral gag and pol genes and viral replication. Journal of Neuorvirololgy. 1997, 3: 274-282. 10.3109/13550289709029468.View ArticleGoogle Scholar
- Lynch WP, Sharpe AH, Snyder EY: Neural stem cells as engraftable packaging lines can mediate gene delivery to microglia: evidence from studying retroviral env-related neurodegeneration. J Virol. 1999, 73: 6841-6851.PubMed CentralPubMedGoogle Scholar
- Chesebro B, Trifilo M, Race R, Meade-White K, Teng C, LaCasse R, Raymond L, Favara C, Baron G, Priola S, et al: Anchorless prion protein results in infectious amyloid disease without clinical scrapie. Science. 2005, 308: 1435-1439. 10.1126/science.1110837.View ArticlePubMedGoogle Scholar
- Albritton LM, Tseng L, Scadden D, Cunningham JM: A putative murine ecotropic retrovirus receptor gene encodes a multiple membrane-spanning protein and confers susceptibility to virus infection. Cell. 1989, 57: 659-666. 10.1016/0092-8674(89)90134-7.View ArticlePubMedGoogle Scholar
- Barnett AL, Davey RA, Cunningham JM: Modular organization of the Friend murine leukemia virus envelope protein underlies the mechanism of infection. PNAS. 2001, 98: 4113-4118. 10.1073/pnas.071432398.PubMed CentralView ArticlePubMedGoogle Scholar
- Snyder EY, Deitcher DL, Walsh C, Arnold-Aldea S, Hartwieg E, Cepko CL: Multipotent neural cell lines can engraft and participate in development of mouse cerebellum. Cell. 1992, 68: 33-51. 10.1016/0092-8674(92)90204-P.View ArticlePubMedGoogle Scholar
- Flynn JA, An W, King SR, Telesnitsky A: Nonrandom dimerization of murine leukemia virus genomic RNAs. J Virol. 2004, 78: 12129-12139. 10.1128/JVI.78.22.12129-12139.2004.PubMed CentralView ArticlePubMedGoogle Scholar
- Davey RA, Hamson CA, Healey JJ, Cunningham JM: In vitro binding of purified murine ecotropic retrovirus envelope surface protein to its receptor, MCAT-1. J Virol. 1997, 71: 8096-8102.PubMed CentralPubMedGoogle Scholar
- Fass D, Davey RA, Hamson CA, Kim PS, Cunningham JM, Berger JM: Structure of a Murine Leukemia Virus Receptor-Binding Glycoprotein at 2.0 Angstrom Resolution. Nature. 1997, 277: 1662-1666.Google Scholar
- Lavillette D, Boson B, Russell SJ, Cosset FL: Activation of membrane fusion by murine leukemia viruses is controlled in cis or in trans by interactions between the receptor-binding domain and a conserved disulfide loop of the carboxy terminus of the surface glycoprotein. J Virol. 2001, 75: 3685-3695. 10.1128/JVI.75.8.3685-3695.2001.PubMed CentralView ArticlePubMedGoogle Scholar
- Anelli T, Sitia R: Protein quality control in the early secretory pathway. Embo J. 2008, 27: 315-327. 10.1038/sj.emboj.7601974.PubMed CentralView ArticlePubMedGoogle Scholar
- Helenius A, Aebi M: Roles of N-linked glycans in the endoplasmic reticulum. Annu Rev Biochem. 2004, 73: 1019-1049. 10.1146/annurev.biochem.73.011303.073752.View ArticlePubMedGoogle Scholar
- Vembar SS, Brodsky JL: One step at a time: endoplasmic reticulum-associated degradation. Nat Rev Mol Cell Biol. 2008, 9: 944-957. 10.1038/nrm2546.PubMed CentralView ArticlePubMedGoogle Scholar
- Gardner MB: Type C viruses of wild mice-Characterization and natural history of amphotropic, ecotropic, and xenotropic MuLV. Curr Top Microbiol Immunol. 1978, 79: 215-259.View ArticlePubMedGoogle Scholar
- Perryman S, Nishio J, Chesebro B: Complete nucleotide sequence of Friend murine leukemia virus, strain FB29. Nucleic Acids Res. 1991, 19: 6950-10.1093/nar/19.24.6950.PubMed CentralView ArticlePubMedGoogle Scholar
- Portis JL, Czub S, Garon CF, McAtee FJ: Neurodegenerative disease induced by the Wild Mouse ecotropic retrovirus is markedly accelerated by long terminal repeat and gag-pol sequences from nondefective Friend murine leukemia virus. J Virol. 1990, 64: 1648-1656.PubMed CentralPubMedGoogle Scholar
- Kozak SL, Kabat D: Ping-pong amplification of a retroviral vector achieves high level gene expression: human growth hormone production. J Virol. 1990, 64: 3500-3508.PubMed CentralPubMedGoogle Scholar
- Ryder EF, Snyder EY, Cepko CL: Establishment and characterization of multipotent neural cell lines using retrovirus vector-mediated oncogene transfer. Jounal of Neurobiology. 1990, 21: 356-375. 10.1002/neu.480210209.View ArticleGoogle Scholar
- Miller AD, Law M-F, Verma IM: Generation of helper-free amphtropic retroviruses that transduce a dominant-acting, methotrexate-resistant dihydrofolate reductase gene. Mol Cell Biol. 1985, 5: 431-437.PubMed CentralView ArticlePubMedGoogle Scholar
- McAtee FJ, Portis JL: Monoclonal antibodies specific for wild mouse neurotropic retrovirus: Detection of comparable levels of virus replication in mouse strains susceptible and resistent to paralytic disease. J Virol. 1985, 56: 1010-1022.Google Scholar
- Lynch WP, Brown WJ, Spangrude GJ, Portis JL: Microglial infection by a neurovirulent murine retrovirus results in defective processing of envelope protein and intracellular budding of virus particles. J Virol. 1994, 68: 3401-3409.PubMed CentralPubMedGoogle Scholar
- Czub M, Czub S, McAtee F, Portis J: Age-dependent resistance to murine retrovirus-induced spongiform neurodegeneration results from CNS-specific restriction of virus replication. J Virol. 1991, 65: 2539-2544.PubMed CentralPubMedGoogle Scholar
- Evans LH, Morrison RP, Malik FG, Portis J, Britt WJ: A neutralizable epitope common to the envelope glycoproteins of ecotropic, polytropic, xenotropic, and amphotropic murine leukemia viruses. J Virol. 1990, 64: 6176-6183.PubMed CentralPubMedGoogle Scholar
- Czub M, McAtee FJ, Portis JL: Murine retrovirus-induced spongiform encephalomyelopathy: host and viral factors which determine the length of the incubation period. J Virol. 1992, 66: 3298-3305.PubMed CentralPubMedGoogle Scholar
- Miller AD, Wolgamot G: Murine retroviruses use at least six different receptors for entry into Mus dunni cells. J Virol. 1997, 71: 4531-4535.PubMed CentralPubMedGoogle Scholar
- Chesebro B, Britt W, Evans L, Wehrly K, Nishio J, Cloyd M: Characterization of monoclonal antibodies reactive with murine leukemia viruses: use in analysis of strains of friend MCF and Friend ecotropic murine leukemia virus. Virology. 1983, 127: 134-148. 10.1016/0042-6822(83)90378-1.View ArticlePubMedGoogle Scholar
- Robertson MN, Miyazawa M, Mori S, Caughey B, Evans LH, Hayes SF, Chesebro B: Production of monoclonal antibodies reactive with a denatured form of the Friend murine leukemia virus gp70 envelope protein: use in a focal infectivity assay, immunohistochemical studies, electron microscopy and western blotting. J Virol Methods. 1991, 34: 255-271. 10.1016/0166-0934(91)90105-9.View ArticlePubMedGoogle Scholar
- Lynch WP, Sharpe AH: Differential glycosylation of the Cas-Br-E env protein is associated with retrovirus-induced spongiform neurodegeneration. J Virol. 2000, 74: 1558-1565. 10.1128/JVI.74.3.1558-1565.2000.PubMed CentralView ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.